Please use this identifier to cite or link to this item: http://adhlui.com.ui.edu.ng/jspui/handle/123456789/1887
Full metadata record
DC FieldValueLanguage
dc.contributor.authorOLUKOYA, D. K.-
dc.date.accessioned2023-02-06T12:22:20Z-
dc.date.available2023-02-06T12:22:20Z-
dc.date.issued1993-09-
dc.identifier.citationAfr. J. Med. med. Sci. (1993) 22(3): 13-15en_US
dc.identifier.issn1116-4077-
dc.identifier.urihttp://adhlui.com.ui.edu.ng/jspui/handle/123456789/1887-
dc.descriptionArticleen_US
dc.description.abstractAbout 30% of clinical isolates of Escherichia coli tested utilized L-sorbose as a carbon and energy source. Escherichia coli K-12 is naturally sorbose negative. The genes for L-sorbose utilization (sor*) is being used as a prototype for studying variable genes amongst bacterial pathogens. The sor* genes from seven isolates were transferable to E. coli K-12. The (sor*) region was cloned into plasmid pBR322 to give pDOK 1. Plasmid pDOK 1 is approximately 20kb in size. A restriction endonuclease map of pDOKl is presented.en_US
dc.description.sponsorshipCollege of Medicineen_US
dc.language.isoenen_US
dc.publisherSpectrum Books Limiteden_US
dc.subjectCloningen_US
dc.subjectPlasmiden_US
dc.subjectEscherichia colien_US
dc.subjectL-sorboseen_US
dc.titleCloning and restriction mapping of the L-sorbose utilization genes from a clinical isolate of Escherichia coli (1)en_US
dc.typeArticleen_US
Appears in Collections:African Journal of Medicine and Medical Sciences

Files in This Item:
File Description SizeFormat 
Olukoya_Cloning_1993.pdfArticle5.32 MBAdobe PDFView/Open


Items in COMUI (ADHL) are protected by copyright, with all rights reserved, unless otherwise indicated.